Focused on Oncology with Potential in Auto-Immunity
Prof. René HOET, PhD
A company that delivers innovation
ImCheck has made rapid advances with first-in-class antibodies that are moving towards the clinic, as well as a wealth of exciting antibody discovery programs addressing novel targets in IO and auto-immunity. I am delighted to put my over 20 years’ experience in antibody discovery and development to bring these molecules to patients in medical need.